TECH & OTHER NEWS

Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo

March 4, 2024

Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo – Technology Today – EIN Presswire

Trusted News Since 1995

A service for technology industry professionals · Monday, March 4, 2024 · 693,123,263 Articles · 3+ Million Readers

Source Link

Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo

LEAVE A REPLY Cancel reply

TECH NEWS

Everything Old is New Again: AI-Driven Development and Open Source

Gen AI in Healthcare: The State of Affairs in India

Gartner Predicts Legal, Risk and Compliance Functions to Double Technology Spend...

Microsoft to End Support for Windows Mail, Calendar and People Apps...

IDC Predicts: Asia/Pacific Business Leaders to Demand 80% Success Rate on...

The Cooling Conundrum: AI and Automation Push Data Centers Toward 3X...

TOP STORIES

Organizations Remain Focused on AI; Most Innovations Not Yet Living Up...

Seventy Percent of Economies Are Underprepared for AI Disruption

New study shows almost half of tech professionals in India believe...

Organizations Combining Organizational Learning and AI-Specific Learning Are up to 80%...

Nvidia’s AI-driven triumph over Intel powered by strategic innovations

Most banks and insurers adopt cloud solutions with the primary objective...

Cyber Security

Deepfake Attacks Are Winning in Crypto: 57% Companies Impacted, Regula’s Study...

AI and Gen AI are set to transform cybersecurity for most...

ThreatQuotient Publishes 2024 Evolution of Cybersecurity Automation Adoption Research Report

Kaspersky predicts quantum-proof ransomware and advancements in mobile financial cyberthreats in...

Rising concerns, lingering gaps: most organizations fear AI-driven cyberattacks but lack...

Tenable Forecasts Data Security in the Cloud to Take Centre Stage...